Boston Scientific Hit by Two Suits Over Handling of Defective ICDs

The GMP Letter
Boston Scientific and its subsidiary, Guidant, are facing a new lawsuit relating to Guidant’s handling of defective implantable cardioverter defibrillators (ICDs) earlier this decade after settling a related suit last month for almost $300 million.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00